[go: up one dir, main page]

AR080832A1 - Liquidos nutricionales estables que comprenden beta-alanina - Google Patents

Liquidos nutricionales estables que comprenden beta-alanina

Info

Publication number
AR080832A1
AR080832A1 ARP110101134A ARP110101134A AR080832A1 AR 080832 A1 AR080832 A1 AR 080832A1 AR P110101134 A ARP110101134 A AR P110101134A AR P110101134 A ARP110101134 A AR P110101134A AR 080832 A1 AR080832 A1 AR 080832A1
Authority
AR
Argentina
Prior art keywords
beta
alanine
alanina
carbohydrate system
include beta
Prior art date
Application number
ARP110101134A
Other languages
English (en)
Inventor
Paul W Johns
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR080832A1 publication Critical patent/AR080832A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un líquido nutricional estable en estante que comprende beta-alanina, proteínas y un sistema de carbohidratos, donde dicho líquido nutricional estable en estante incluye una relacion molar entre el DE del sistema de carbohidratos y el nitrogeno de amina de la lisina de la proteína menor que 1,0 aproximadamente y una relacion molar entre el DE del sistema de carbohidratos y la beta-alanina menor que 3,0 aproximadamente. Los líquidos nutricionales son sorprendentemente estables sobre períodos de tiempo prolongados y presentan una reduccion mínima de la concentracion de beta-alanina durante la vida en estante.
ARP110101134A 2010-04-05 2011-04-05 Liquidos nutricionales estables que comprenden beta-alanina AR080832A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32091310P 2010-04-05 2010-04-05

Publications (1)

Publication Number Publication Date
AR080832A1 true AR080832A1 (es) 2012-05-09

Family

ID=43919907

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101134A AR080832A1 (es) 2010-04-05 2011-04-05 Liquidos nutricionales estables que comprenden beta-alanina

Country Status (5)

Country Link
US (1) US20110250340A1 (es)
AR (1) AR080832A1 (es)
CL (1) CL2011000746A1 (es)
TW (1) TW201201713A (es)
WO (1) WO2011127039A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201320908A (zh) * 2011-10-13 2013-06-01 Abbott Lab 包含β－丙胺酸之營養產品
EP3092906A1 (en) * 2012-01-03 2016-11-16 Nestec S.A. Compositions and methods for the stability of reactive amino acids in a liquid food product
EP2641477B2 (de) 2012-03-19 2022-06-08 Symrise AG Stoffgemische
HUE047629T2 (hu) * 2013-01-28 2020-05-28 Lopez Hector L Eljárások ß-alanin tolerancia, farmakodinamika és hatékonyság javítására és azok alkalmazása
WO2017134245A1 (en) * 2016-02-03 2017-08-10 Fresenius Kabi Deutschland Gmbh High caloric, high protein nutritional formula comprising collagen
CN106831466B (zh) * 2016-12-28 2018-05-22 安徽省虹升生物股份有限公司 一种β-丙氨酸的常规储存方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2039709A (en) * 1979-01-04 1980-08-20 Johnson & Johnson Preventing the Maillard Reaction in Dietary Foods
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
US5514655A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Enteral nutritional with protein system containing soy protein hydrolysate and intact protein
US5641531A (en) * 1995-09-28 1997-06-24 Abbott Laboratories Nutritional liquid supplement beverage and method of making same
WO1998004255A1 (en) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
US6475539B1 (en) * 1998-05-07 2002-11-05 Abbott Laboratories Nutritionally complete low pH enteral formula
JP2000072669A (ja) * 1998-08-24 2000-03-07 Inst Of Physical & Chemical Res アミノ酸・糖組成物
US7645470B2 (en) * 2005-04-20 2010-01-12 Abbott Laboratories Iron-fortified, milk-based, flavored beverages with improved color
CN101309688B (zh) * 2005-05-23 2016-06-22 自然选择国际公司 持续释放β-丙氨酸的组合物和方法
US20080194407A1 (en) * 2007-02-14 2008-08-14 Ashmead H Dewayne High nitrogen containing chelate compositions suitable for plant delivery
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
US20090312419A1 (en) * 2009-08-12 2009-12-17 Kneller Bruce W CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE

Also Published As

Publication number Publication date
CL2011000746A1 (es) 2011-10-14
US20110250340A1 (en) 2011-10-13
WO2011127039A1 (en) 2011-10-13
TW201201713A (en) 2012-01-16

Similar Documents

Publication Publication Date Title
AR080832A1 (es) Liquidos nutricionales estables que comprenden beta-alanina
CY1124703T1 (el) Μεθοδοι και συνθεσεις για παραδοση της ιδουρονικης-2-σουλφατασης στο κνς
AR081872A1 (es) Liquidos nutricionales sustancialmente limpidos que comprenden hmb de calcio y proteinas solubles
ATE493161T1 (de) Medizinisches abgabesystem mit asymmetrischen kodiervorrichtungen
MX352823B (es) Formulaciones de proteinas que contienen aminoacidos.
MY160552A (en) Low protein infant formula with increased essential amino acids
MX2013008647A (es) Metodo, composiciones y empaque para limpieza del intestino.
MX375672B (es) Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9.
AR089787A1 (es) Formulaciones estabilizadas que contienen anticuerpos anti-ang2
MX377249B (es) Adhesivos antimicrobianos que tienen propiedades mejoradas .
PE20160527A1 (es) Formulaciones de adenovirus mejoradas
WO2014100481A3 (en) Modified alpha hemolysin polypeptides and methods of use
UY35859A (es) ?combinación farmacéutica que comprende amlodipina, losartán y rosuvastatina?.
AR091530A1 (es) Formulacion farmaceutica liquida de un anticuerpo y acetato
AR089203A1 (es) Formulacion farmaceutica liquida que comprende ketoprofeno, amitriptilina y oximetazolina y metodo de tratamiento
PH12014500054A1 (en) Formulations that stabilize proteins
IN2014DN06121A (es)
AR090244A1 (es) Formulacion de anticuerpo anti-selectina p
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.
CL2011002926A1 (es) Solucion farmaceutica que tiene un ph de 10 o superior, que contiene telmisartan en concentracion de 1 a 10mg/ml y uno o mas azucar-alcoholes en concentracion de 40-70% (de preferencia 60-70%); metodo de preparacion; uso para el tratamiento de la hipertension o lesiones renales; y recipiente de vidrio o plastico que la contiene.
MX2014008024A (es) Fortificante líquido concentrado de lecha humana, de baja actividad de agua, que incluye proteína extensamente hidrolizada.
Swetz et al. In the clinic. Palliative care
MX2021014310A (es) Formulaciones de terlipressina.
PH12013502250A1 (en) Construction material preservative
NZ594300A (en) A housing for an oral hygiene and medication device and an assembly thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal